HomeNXEN • OTCMKTS
add
Nexien Biopharma Inc
Previous close
$0.0097
Year range
$0.0041 - $0.050
Market cap
686.49K USD
Avg Volume
4.37K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.30K | -10.33% |
Net income | -30.09K | 43.40% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.28K | -17.70% |
Total assets | 8.28K | -41.93% |
Total liabilities | 458.80K | 35.12% |
Total equity | -450.52K | — |
Shares outstanding | 70.77M | — |
Price to book | -0.97 | — |
Return on assets | -745.61% | — |
Return on capital | 48.70% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -30.09K | 43.40% |
Cash from operations | -13.02K | 37.85% |
Cash from investing | — | — |
Cash from financing | 20.00K | -29.58% |
Net change in cash | 6.98K | -6.30% |
Free cash flow | -4.00K | 82.65% |
About
Founded
1952
Website
